admin

Covid-19 related stocks started spiking again this week. Driven primarily by reports about new variants and increasing spread. This news has been a shot in the arm for some struggling pharma stocks. Shares of the four biggest Covid vaccine manufacturers are down 20% since January but began ticking upward again on the news. Already pharmaceutical
At the start of August, cybersecurity company Fortinet (NASDAQ:FTNT) issued financial results that missed Wall Street’s revenue expectations. Worse, the company lowered its forward guidance. This sent FTNT stock down 25% in a single trading session, its worst single-day price drop ever. The demise of Fortinet has cast a cloud over the entire cybersecurity sector,
In recent years, the argument against dual-class stock investment has heated up considerably. Some feel they should be outlawed completely. In March 2019, I argued that the problem isn’t the share structure but the people running these companies. The share structure doesn’t stand in the way of market-beating returns in the hands of reasonable management
Everybody and his uncle knows that Nvidia (NASDAQ:NVDA) will benefit from the popularity of artificial intelligence (AI) in 2023. This is already known and priced into NVDA stock. Therefore, value-seekers and contrarians shouldn’t be too eager to invest in Nvidia now. By the time you read this, Nvidia may have already published its second-quarter earnings results.